Hot Trucking Companies To Own For 2015: JinkoSolar Holding Company Limited(JKS)
JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of solar power products in China and internationally. The company provides solar modules, silicon wafers and ingots, and solar cells, as well as processing services, including silicon wafer tolling services. It sells its products under the JinkoSolar brand name. The company?s customers include distributors, project developers, and system integrators. It trades its products under short-term contracts and by spot market sales. The company also produces accessory materials for solar power products, such as solar aluminum frame, solar junction box, aluminum materials windows, and other metal component parts. JinkoSolar Holding Co., Ltd. was founded in 2006 and is based in Shangrao, the People?s Republic of China.
Advisors' Opinion:- [By Maria Armental var popups = dojo.query(".socialByline .popC"); popups.forEach]
Yingli Green said it will continue to fight a U.S. plan to close a loophole that allowed Chinese solar manufacturers to avoid tariffs by assembling their products outside China. Yingli shares dropped 6.4% to $2.76 premarket. Among the other Chinese solar stocks trading lower Wednesday are JinkoSolar Holding Co.(JKS), Trina Solar Ltd.(TSL) and JA Solar Holdings Co.(JASO)
- [By Seth Jayson]
JinkoSolar Holding (NYSE: JKS ) reported earnings on June 7. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), JinkoSolar Holding beat expectations on revenues and exceeded expectations on earnings per share. - [By Travis Hoium]
What: Solar stocks are shooting higher again today as the strong run in 2013 continues. LDK Solar (NYSE: LDK ) , Canadian Solar (NASDAQ: CSIQ ) , Yingli Green Energy (NYSE: YGE ) , Hanwha SolarOne (NASDAQ: HSOL ) , and JinkoSolar (NYSE: JKS ) led the way, gaining between 10% and 22% today.
- [By Travis Hoium]
JinkoSolar (NYSE: JKS ) �and Canadian Solar (NASDAQ: CSIQ ) have slightly better balance sheets and they're focusing on expanding into systems, which will smooth out demand. JinkoSolar has a $1 billion financing deal with the China Development Bank to build projects, not just manufacturing capacity, which will help demand. Canadian Solar has built a huge systems business in Canada, including a $310 million, 130 MW project last month, and signed 18 MW of deals in South Carolina last week. The systems business generates stable demand and allows companies to compete more than on price alone, which helps margins.�
5 Best Safest Stocks To Invest In Right Now: Yahoo! Inc.(YHOO)
Yahoo! Inc., together with its subsidiaries, operates as a digital media company that delivers personalized digital content and experiences through various devices worldwide. It offers online properties and services to users; and a range of marketing services to businesses. The company?s communications and communities offerings include Yahoo! Mail, Yahoo! Messenger, Yahoo! Groups, Yahoo! Answers, Flickr, and Connected TV, which provide a range of communication and social services to users and small businesses enabling users to organize into groups and share knowledge, common interests, and photos. Its search products comprise Yahoo! Search and Yahoo! Local, available free to users to navigate the Internet and discover content. The company?s marketplaces offerings and services include Yahoo! Shopping, Yahoo! Travel, Yahoo! Real Estate, Yahoo! Autos, and Yahoo! Small Business, which allow users to research specific topics, products, services, or areas of interest by review ing and exchanging information, obtaining contact details, or considering offers from providers of goods, services, or parties with similar interests. Its media offerings comprise Yahoo! Homepage, Yahoo! News, Yahoo! Sports, Yahoo! Finance, My Yahoo!, Yahoo! Toolbar, Yahoo! Entertainment & Lifestyles, Yahoo! Contributor Network, and Yahoo! Pulse, which are designed to engage users with online content and services on the Web. The company also offers marketing services, such as display and search advertising, listing-based services, and commerce-based transactions to advertisers. In addition, it provides software and platform offerings for third-party developers, advertisers, and publishers, such as Yahoo! Developer Network, Yahoo! Open Strategy, Yahoo! Application Platform, Yahoo! Updates, Yahoo! Query Language, and Yahoo! Search BOSS. The company has strategic alliances with Nokia and ABC News, Inc. Yahoo! Inc. was founded in 1994 and is headquartered in Sunnyvale, Californi a.
Advisors' Opinion:- [By Garrett Cook]
Yahoo (NASDAQ: YHOO) was down, falling 5.07 percent to $33.81 after the company reported weaker-than-expected second-quarter results. The company announced it will reduce the number of shares being offered in the Alibaba IPO from 208 million shares to 140 million shares.
- [By Benjamin Pimentel]
Other major tech issues were in the red, including Yahoo Inc. (YHOO) �, AOL Inc. (AOL) �and Groupon Inc. (GRPN) .
- [By Travis Hoium]
Microsoft also agreed to extend a revenue-per-search guarantee for Yahoo! (NASDAQ: YHOO ) . This is part of the search partnership the companies formed in 2010, which has not yet challenged the search dominance of Google.�
- [By Dan Radovsky]
AllThings D also reports that bids have to be at least $1 billion, and DIRECTV (NASDAQ: DTV ) is said to be ready with a bid of at least that much. Time Warner Cable (NYSE: TWC ) , Yahoo! (NASDAQ: YHOO ) , and the private-equity firms KKR, Guggenheim Digital, and Silverlake Partners are also ready to compete.
5 Best Safest Stocks To Invest In Right Now: Rallye SA (RAL)
Rallye SA is a France-based holding company organized around two sectors of activity: large scale distribution to the food stores and supermarkets and distribution of sports items. The Company is present in France, Latin America, Poland, and Asia through its interests in brands, such as Geant, Monoprix, Leader Price, and United Grocers Cash & Carry, among others. It also has its interst in the Groupe Go Sport. Rallye SA is notably present in France, the United States, Luxembourg, Poland and Colombia, among others. The Company operates through its subsidiaries and affliated companies, such as Cobivia SAS, L��abitation Moderne de Boulogne, Magasins Jean SAS, Matignon Sablons SAS, MFD SA, Parande SAS, Casino Guichaqrd Perrachon DA, Groupe Go Sport, Sivigral SCI and French Develompent Venture SA. Advisors' Opinion:- [By Holly LaFon]
A risk involved with the company is that its Republic Bank & Trust business derives 78% of its net income from TRS, which offers bank products that help get customers who electronically file their tax returns their payments. RB&T is only of the few financial institutions in the U.S. that provide the service. Under the program, the taxpayer may receive a Refund Anticipation Loan (RAL), which has been questioned by various governmental and consumer groups. In May 2011, RB&T received an order to cease and desist which could result in an order by the FDIC to terminate its RAL program. It has a hearing on Feb. 12, 2012 in Kentucky regarding the matter.
5 Best Safest Stocks To Invest In Right Now: Theravance Inc.(THRX)
Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines for various therapeutic areas, including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. The company?s key development programs with GlaxoSmithKline (GSK) include the RELOVAIR, a Phase 3 clinical trial program for the treatment of patients with chronic obstructive pulmonary disease (COPD) and/or asthma; the LAMA/LABA program, a Phase 3 COPD program; and the Bifunctional Muscarinic Antagonist-beta2 Agonist (MABA) program, a Phase 2b program for the treatment of COPD, as well as Peripherally Selective Mu-Opioid Receptor Antagonist (P Advisors' Opinion:
- [By Brian Orelli]
Following in the footsteps of Abbott spinning out its drug division into AbbVie (NYSE: ABBV ) , and Pfizer spinning out its animal health division into animal health products into Zoetis, Theravance (NASDAQ: THRX ) is splitting up.
- [By Sean Williams]
Perhaps the most exciting new treatment to hit the market in years was recently approved by the FDA. Developed by GlaxoSmithKline (NYSE: GSK ) and Theravance (NASDAQ: THRX ) , Breo Ellipta is a dry powder drug delivered by inhaler and meant to provide long-term relief of air-flow obstruction and reduce COPD exacerbations. The two companies are collaborating on a handful of potentially revolutionary new COPD treatments that combine Theravance's long-acting beta-2 agonists with Glaxo's long-acting muscarinic antagonists. Its next treatment, Breo Anoro, is currently under review by the FDA.
- [By Sean Williams]
On the bright side, GlaxoSmithKline (NYSE: GSK ) and Theravance (NASDAQ: THRX ) received a much-expected drug approval for once-daily inhaled COPD maintenance treatment Breo Ellipta from the Food and Drug Administration. Having proved non-inferior to the placebo in trials, and delivering a favorable safety profile while reducing flare-ups and helping relieve air flow obstruction, Breo Ellipta has a good shot at being a blockbuster drug within the next couple of years. Breo Ellipta is expected to be available to patients next quarter. In addition, as I've alluded to on numerous occasions, it could be the impetus that encourages Glaxo to gobble up Theravance's Royalty Management -- one of two proposed entities that Theravance plans to split into. This is certainly a big win for both companies.
- [By Jonas Elmerraji]
First up is $4 billion biopharmaceutical firm Theravance (THRX). It's been one heck of a year already for THRX's shareholders. Since the calendar flipped over to January, shares of the firm have rallied more than 75%. But the setup forming in shares points to even higher ground for the final quarter of 2013.
That's because Theravance is currently forming an ascending triangle pattern, a bullish setup that's formed by a horizontal resistance level above shares at $42 and uptrending support to the downside. Basically, as Theravance bounces in between those two technical levels, it's getting squeezed closer and closer to a breakout above that $42 resistance level. When that happens, traders have a buy signal.
Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Ascending triangles and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable. Instead, it all comes down to supply and demand for shares.
That $42 is a price where there has been an excess of supply of shares; in other words, it's a place where sellers have been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above it so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level.
Don't be early on this trade.
No comments:
Post a Comment